Robert Liptak is Director at GLOBUS MEDICAL INC (GMED). They have made 10 open-market trades across 6 companies since 2010, most recently 2016-01-28.
CIK 0001237831
2 open-market purchases totalling $17.0M since 2011, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZGNX | 9,482,439 | $253.0M |
| AERI | 3,499,259 | $53.4M |
| OXFD | 2,397,628 | $52.7M |
| GMED | 41,159 | $3.6M |
| OPHT | 2,542,373 | $3.5M |
| TLOG | 4,575,280 | $504K |
| AVNR | 8,246,414 | — |
| Total | $366.7M |
Shares reported on the most recent Form 4, priced at the 2016-01-28 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 80% |
| Avg Move | -22.5% | -13.8% | +6.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLOG | SELL | 2016-01-26 | 2016-01-28 | $0.27 | $143K | -42.3% | -56.4% | +46.1% |
| GMED | SELL | 2016-01-04 | 2016-01-06 | $27.50 | $421K | -5.6% | -14.8% | -10.2% |
| OXFD | SELL | 2015-03-20 | 2015-03-24 | $14.49 | $774K | -10.6% | -4.9% | -4.9% |
| AERI | SELL | 2015-01-05 | 2015-01-06 | $30.86 | $729K | -25.9% | -2.5% | -2.5% |
| AERI | SELL | 2014-12-26 | 2014-12-30 | $30.05 | $2.4M | -25.9% | -2.5% | -2.5% |
| TLOG | BUY | 2013-12-17 | 2013-12-19 | $7.00 | $10.0M | -81.5% | +0.5% | +0.5% |
| GMED | SELL | 2013-12-06 | 2013-12-10 | $19.36 | $484K | -7.9% | -2.9% | -2.9% |
| GMED | SELL | 2012-08-08 | 2012-08-10 | $11.16 | $9.0M | -7.9% | -2.9% | -2.9% |
| ZGNX | BUY | 2011-09-16 | 2011-09-20 | $2.00 | $7.0M | -27.8% | -4.8% | -4.8% |
| AVNR | SELL | 2010-11-03 | 2010-11-05 | $4.57 | $7.9M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.